1. Home
  2. GMGI vs FDMT Comparison

GMGI vs FDMT Comparison

Compare GMGI & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMGI
  • FDMT
  • Stock Information
  • Founded
  • GMGI 2008
  • FDMT 2013
  • Country
  • GMGI United States
  • FDMT United States
  • Employees
  • GMGI N/A
  • FDMT N/A
  • Industry
  • GMGI Computer Software: Prepackaged Software
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GMGI Technology
  • FDMT Health Care
  • Exchange
  • GMGI Nasdaq
  • FDMT Nasdaq
  • Market Cap
  • GMGI 263.6M
  • FDMT 268.6M
  • IPO Year
  • GMGI N/A
  • FDMT 2020
  • Fundamental
  • Price
  • GMGI $2.05
  • FDMT $4.67
  • Analyst Decision
  • GMGI
  • FDMT Buy
  • Analyst Count
  • GMGI 0
  • FDMT 11
  • Target Price
  • GMGI N/A
  • FDMT $41.70
  • AVG Volume (30 Days)
  • GMGI 138.6K
  • FDMT 1.1M
  • Earning Date
  • GMGI 03-13-2025
  • FDMT 02-27-2025
  • Dividend Yield
  • GMGI N/A
  • FDMT N/A
  • EPS Growth
  • GMGI N/A
  • FDMT N/A
  • EPS
  • GMGI 0.40
  • FDMT N/A
  • Revenue
  • GMGI $87,563,172.00
  • FDMT $17,000.00
  • Revenue This Year
  • GMGI $17.07
  • FDMT N/A
  • Revenue Next Year
  • GMGI N/A
  • FDMT $159.49
  • P/E Ratio
  • GMGI $5.05
  • FDMT N/A
  • Revenue Growth
  • GMGI 45.05
  • FDMT N/A
  • 52 Week Low
  • GMGI $1.86
  • FDMT $4.48
  • 52 Week High
  • GMGI $6.27
  • FDMT $36.25
  • Technical
  • Relative Strength Index (RSI)
  • GMGI 46.60
  • FDMT 32.64
  • Support Level
  • GMGI $2.00
  • FDMT $4.68
  • Resistance Level
  • GMGI $2.30
  • FDMT $5.15
  • Average True Range (ATR)
  • GMGI 0.18
  • FDMT 0.41
  • MACD
  • GMGI 0.02
  • FDMT -0.05
  • Stochastic Oscillator
  • GMGI 25.68
  • FDMT 8.69

About GMGI Golden Matrix Group Inc.

Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: